Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018
Early recombinant zoster vaccine safety monitoring findings are consistent with prelicensure clinical trial data. Serious adverse events were rare, and no unexpected patterns were detected. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 31, 2019 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Vaccine Safety Source Type: news

Herpes zoster infection
This review covers who is at risk, typical presentation, complications, infectiousness, when to prescribe antivirals and which antiviral, when to refer, use of analgesia, latest vaccine recommendations and the difference between Zostavax and Shingrix. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2019 Category: Consumer Health News Source Type: news

Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S. Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S.
Shingles is becoming less common in both adults and children in the U.S., according to results from a database study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 26, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Higher Risk of Shingles Seen in Patients With Certain Cancers
(MedPage Today) -- Vaccine development may help with prevention of herpes zoster in this population (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 14, 2018 Category: Hematology Source Type: news

Herpes zoster (shingles) immunisation programme 2017 to 2018: evaluation report
This report evaluates the fifth year of the shingles vaccination programme in England from 2017 to 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2018 Category: Consumer Health News Source Type: news

Herpes Zoster Recombinant Vaccine Seems Most Effective
THURSDAY, Nov. 8, 2018 -- The herpes zoster adjuvant recombinant subunit vaccine may be more effective than the live attenuated vaccine, though it is associated with an increased risk for adverse events at the injection site, according to a review... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 8, 2018 Category: Pharmaceuticals Source Type: news

Pork gelatine in vaccines 'puts many off using them', vegetarians say
Gelatine is added as a stabiliser to prevent vaccines degrading in transportation. In the UK, the worst offenders are the nasal flu vaccine Fluenz Tetra, the shingles jab Zostavax and the MMR. (Source: the Mail online | Health)
Source: the Mail online | Health - October 26, 2018 Category: Consumer Health News Source Type: news

Study: Newer shingles vaccine far more effective
The newer shingles vaccine Shingrix was far more successful in preventing the condition compared with the older vaccine Zostavax among patients 50 and older. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 26, 2018 Category: Consumer Health News Source Type: news

Systematic review of clinical studies suggests newer shingles vaccine far more effective
(St. Michael's Hospital) A systematic review of clinical studies involving more than two million patients aged 50 years and older suggests the newer shingles vaccine Shingrix was far more successful in preventing the painful condition compared to the older vaccine Zostavax. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 25, 2018 Category: International Medicine & Public Health Source Type: news

Colorado parents are holding 'chickenpox parties' to infect their kids
The group in Boulder, part of a growing anti-vaxxer movement, believe infecting their kids is safer than getting a varicella zoster vaccine, and they wrongly claim it's advice from the NHS and CDC. (Source: the Mail online | Health)
Source: the Mail online | Health - October 18, 2018 Category: Consumer Health News Source Type: news

Consumer Health: Shingles -- if you're over 50, get your vaccination
Shingles: Vaccination can lower your risk? Shingles is a viral infection caused by the varicella-zoster virus ? the same virus that causes chickenpox. After you've had chickenpox, the virus remains inactive in nerve tissue near your spinal cord and brain. Years later, the virus may reactivate as shingles, causing a painful skin rash along nerve [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 28, 2018 Category: Databases & Libraries Source Type: news

Shingrix Vaccine Makes Shingles Less Severe, Disruptive to Quality of Life Shingrix Vaccine Makes Shingles Less Severe, Disruptive to Quality of Life
The recombinant zoster vaccine Shingrix prevents shingles, and if people do contract the virus, it reduces the severity of illness, two company-funded studies suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Shingrix (Zoster Vaccine Recombinant, Adjuvanted Suspension for Intramuscular Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 27, 2018 Category: Drugs & Pharmacology Source Type: news

Most Eligible IBD Patients Don't Get Shingles Vaccine Most Eligible IBD Patients Don't Get Shingles Vaccine
Just one in five patients with inflammatory bowel disease (IBD) who are eligible for the herpes zoster (HZ) vaccine actually receive it, according to new study in VA patients.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Age Threshold of 50 for New Zoster Vaccine Not Cost-Effective: Study Age Threshold of 50 for New Zoster Vaccine Not Cost-Effective: Study
The new Advisory Committee on Immunization Practices (ACIP) guideline that recommends the new recombinant adjuvanted zoster subunit vaccine (RZV) over the live attenuated zoster vaccine (ZVL) and lowers the vaccination age to 50 years is not cost-effective, according to a new analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news